AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Diaceutics PLC

163p +$34.50 (+26.85%)
LSE · 16 Sep 2026 08:00 UTC
Previous Close
160p
Day Range
157p163p
Year Range
125p180p
Market Cap
137.95M
AVG Volume
210.73K
Trailing/Forward PE
1481.82/4015.57
PEG ratio
6.29
Dividend Yield
-
Next Earnings Date
2026-09-22
Primary Exchange
London Stock ExchangeUK
Revenue (GBP)
010M20M30M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Revenue (GBP) by quarter
PeriodRevenue (GBP)
25 Q423.87M
25 Q214.56M
24 Q419.84M
24 Q212.32M
23 Q413.78M
23 Q29.92M
22 Q411.98M
22 Q27.53M
21 Q47.98M
21 Q25.97M
Net Income (GBP)
-4M-2M02M4M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Net Income (GBP) by quarter
PeriodNet Income (GBP)
25 Q42.5M
25 Q2-2.4M
24 Q4881K
24 Q2-2.58M
23 Q4-261K
23 Q2-1.49M
22 Q41.49M
22 Q2-767K
21 Q4896K
21 Q2-335K
Operating Income (GBP)
-4M-2M02M4M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Operating Income (GBP) by quarter
PeriodOperating Income (GBP)
25 Q43.14M
25 Q2-3.35M
24 Q41.13M
24 Q2-3.59M
23 Q4-845K
23 Q2-2.17M
22 Q41.62M
22 Q2-1.16M
21 Q41.03M
21 Q2-675K
EBITDA (GBP)
-2M02M4M6M8M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L EBITDA (GBP) by quarter
PeriodEBITDA (GBP)
25 Q46.25M
25 Q2-1.34M
24 Q44.04M
24 Q2-961K
23 Q42.34M
23 Q220K
22 Q43.41M
22 Q2196K
21 Q42.03M
21 Q2152K
Cash Flows (GBP)
-4M-2M02M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Cash Flows (GBP) by quarter
PeriodCash Flows (GBP)
25 Q4680K
25 Q2550K
24 Q4-540K
24 Q21.44M
23 Q4549K
23 Q2-2M
22 Q4-606K
22 Q2884K
21 Q4-3.56M
21 Q2-1.47M
EPS (GBP)
-0.04-0.0200.020.0421 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L EPS (GBP) by quarter
PeriodEPS (GBP)
25 Q40.03
25 Q2-0.03
24 Q40.01
24 Q2-0.03
23 Q4-0
23 Q2-0.02
22 Q40.02
22 Q2-0.01
21 Q40.01
21 Q2-0
Expenses (GBP)
05M10M15M20MR&DSG&ACapex21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Expenses (GBP) by quarter
PeriodExpenses (GBP)
25 Q413.16M
25 Q215.49M
24 Q416.46M
24 Q212.27M
23 Q411.97M
23 Q212.04M
22 Q410.99M
22 Q28.58M
21 Q48.08M
21 Q27.73M
Cash & Debt (GBP)
010M20M30MCashLong Term DebtShort Term Debt21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Cash & Debt (GBP) by quarter
PeriodCash & Debt (GBP)
25 Q47.34M
25 Q210.38M
24 Q412.74M
24 Q216.75M
23 Q416.67M
23 Q217.88M
22 Q419.84M
22 Q220.39M
21 Q419.68M
21 Q223.75M
Debt ratios
-10-7.5-5-2.5021 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Debt ratios by quarter
PeriodDebt ratios
25 Q4-0.78
25 Q2-2.27
24 Q4-2.15
24 Q2-3.25
23 Q4-2.59
23 Q2-2.94
22 Q4-3.2
22 Q2-8.98
21 Q4-8.62
21 Q2-8.8
Margins
0%25%50%75%100%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Margins by quarter
PeriodMargins
25 Q468.2%
25 Q282.99%
24 Q488.41%
24 Q269.91%
23 Q479.9%
23 Q269.79%
22 Q484.47%
22 Q266.94%
21 Q478.59%
21 Q272.02%
Return on Capital
-10%-5%0%5%10%21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Return on Capital by quarter
PeriodReturn on Capital
25 Q46.17%
25 Q2-6.45%
24 Q42.21%
24 Q2-6.67%
23 Q4-0.64%
23 Q2-3.62%
22 Q43.51%
22 Q2-1.87%
21 Q42.2%
21 Q2-0.84%
Shares Outstanding
025M50M75M100M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Shares Outstanding by quarter
PeriodShares Outstanding
25 Q484.68M
25 Q242.27M
24 Q484.73M
24 Q284.45M
23 Q484.19M
23 Q284.23M
22 Q484.26M
22 Q284.11M
21 Q483.99M
21 Q284.07M
Book Value Per Share (GBP)
00.250.50.75121 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Book Value Per Share (GBP) by quarter
PeriodBook Value Per Share (GBP)
25 Q40.48
25 Q20.88
24 Q40.47
24 Q20.46
23 Q40.48
23 Q20.49
22 Q40.5
22 Q20.49
21 Q40.48
21 Q20.48
Total Assets (GBP)
020M40M60M21 Q221 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q4
DXRX.L Total Assets (GBP) by quarter
PeriodTotal Assets (GBP)
25 Q450.01M
25 Q244.42M
24 Q448.62M
24 Q245.43M
23 Q446.34M
23 Q246.12M
22 Q448.26M
22 Q245.53M
21 Q445.01M
21 Q242.49M
Diaceutics PLC
DXRX.L
Stockpicker

Video analysis: DXRX.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.